Sunita Mulpuru profile picture

Contact Information

Sunita Mulpuru, MD FRCPC MSc

smulpuru@ohri.ca

The Ottawa Hospital
General Campus
Box 211, Ottawa, ON
K1H 8L6

Office Fax: 613 737 8319
Office Phone: 613 737 8899 ext 72772

ORCID logo https://orcid.org/0000-0001-6214-0613

Sunita Mulpuru

Associate Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Staff Respirologist, Division of Respirology
The Ottawa Hospital
Assistant Professor, Department of Medicine
University of Ottawa

Research Interests

 

•   Respiratory viral infections: epidemiology and outcomes

•   Respiratory Infection Control in Hospitals

•   Improving models of care for frail patients with COPD 


Brief Biography

Dr. Sunita Mulpuru is a staff Respirologist at The Ottawa Hospital, Assistant Professor at the University of Ottawa, and Associate Scientist at the Ottawa Hospital Research Institute.

She obtained her MD degree from McMaster University, and completed clinical training in Internal Medicine with a specialization in Respiratory Medicine at the University of Ottawa.  Following this, she pursued the Clinician Investigator Program and a Masters of Science in Epidemiology at the University of Ottawa.

Selected Publications

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.
Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).
Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.


Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.
Cowan J, Mulpuru S, Aaron S, Alvarez G, Giulivi A, Corrales-Medina V, Thiruganasambandamoorthy V, Thavorn K, Mallick R, Cameron DW.
Pilot Feasibility Stud. 2018 Aug 11;4:135. doi: 10.1186/s40814-018-0327-z. eCollection 2018.


Factors contributing to high-cost hospital care for patients with COPD.
Mulpuru S, McKay J, Ronksley PE, Thavorn K, Kobewka DM, Forster AJ.
Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;12:989-995. eCollection 2017.


Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: Risk factors and implications for infection control.

Mulpuru S, Knoll G, Weir C, Desjardins M, Johnson D, Gorn I, Fairhead T, Bissonnette J, Bruce N, Toye B, Suh K, Roth V.
Am J Infect Control. 2016 Apr 1;44(4):425-31.


Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients.

Mulpuru S, Aaron SD, Ronksley PE, Lawrence N, Forster AJ.
Emerg Infect Dis. 2015 Aug;21(8):1366-71.


Antibiotics for community-acquired pneumonia in adult outpatients.
Pakhale S, Mulpuru S, Verheij TJ, Kochen MM, Rohde GG, Bjerre LM.
Cochrane Database Syst Rev. 2014 Oct 9;10:CD002109.


Evaluation of 3 electronic methods used to detect influenza diagnoses during 2009 pandemic.
Mulpuru S, Smith T, Lawrence N, Wilson K, Forster AJ.
Emerg Infect Dis. 2013 Dec;19(12):2062-3.


Influenza infection screening tools fail to accurately predict influenza status for patients during pandemic H1N1 influenza season.

Mulpuru S, Roth VR, Lawrence N, Forster AJ.
Can Respir J. 2013 May-Jun;20(3):e55-9.


Incidence of potentially avoidable urgent readmissions and their relation to all-cause urgent readmissions.

van Walraven C, Jennings A, Taljaard M, Dhalla I, English S, Mulpuru S, Blecker S, Forster AJ.
CMAJ. 2011 Oct 4;183(14):E1067-72. 

Diseases, conditions and populations of interest





Research and clinical approaches